Prefilled Syringes Market Size Grows as Safety Becomes Paramount
The pharmaceutical industry is experiencing a significant transformation driven by advanced technology and improved drug delivery methods, with a notable shift from traditional glass syringes to disposable plastic syringes and the emerging popularity of prefilled syringes (PFS). Prefilled syringes, single-dose packets of preparation used to package injectable drugs and diluents, are gaining traction due to their safety and convenience, as they are disposed of after a single use.
In addition to packaging parenteral drugs, prefilled syringes are increasingly being considered for other product categories, including vaccines, blood stimulants, therapeutic proteins, erythroproteins, and interferons. The growing demand for sterile, convenient, accurate, and affordable parenteral drug delivery is driving sales of prefilled syringes in the global market.
User-friendly Features and Accurate Dosage for Self-administration
Prefilled syringes offer several advantages, including the reduction of the risk of microbial ingress and product cross-contamination, thus enhancing patient safety. Unlike vials that are often overfilled up to 25%, prefilled syringes contain the exact dose, helping eliminate dosing errors. Prefilled syringes simplify the drug preparation process, benefiting both patients and healthcare providers.
With the rise of biotechnology drugs at higher price points, prefilled syringes have emerged as a cost-effective solution that promotes reduced waste, making them invaluable in cases of vaccine shortages and for expensive medications. Pharmaceutical companies can extend a product’s shelf life, while patients can self-administer injectable drugs in the comfort of their homes. Prefilled syringes also play a crucial role in emergency situations and serve as an ideal drug delivery solution in remote areas. They facilitate the self-administration of monoclonal antibodies used in managing multiple chronic conditions, further driving the growth of the prefilled syringes market.
Stability and Safety Challenges Persist
Despite the growing use of prefilled syringes in the pharmaceutical and medical industries, manufacturers must ensure that the primary packaging does not negatively interact with drugs. Any such interaction can lead to stability issues, including extractables and leachables (E&L) that can compromise the effectiveness of drugs. Addressing these challenges remains essential for the rapid growth of the prefilled syringes market. Additionally, developing cost-effective alternatives and reducing the risk of needlestick injuries continue to be concerns for manufacturers.
Single-chamber Prefilled Syringes on the Rise
Single-chamber prefilled syringes are poised for increased demand due to their simple storage and disposal requirements, reduced drug waste during clinical trials, decreased material usage, and optimized active pharmaceutical ingredient (API) utilization. These syringes are benefiting from the expansion of home healthcare settings and the growing acceptance of self-administered routine drugs among patients with chronic diseases. The rising adoption of self-administered parenteral drugs and the increasing prevalence of chronic diseases collectively contribute to the rising sales of prefilled syringes in the global market.
European Market Leads the Way
The North American and European markets are at the forefront of global prefilled syringes demand. These regions lead due to frequent product launches and robust distribution networks of key manufacturers. European markets, in particular, are performing well, with increasing adoption of prefilled syringes for self-injecting drug devices, higher consumption of biologics and biosimilars, and substantial investments from industry leaders in the region. Regional players are also expanding geographically, further bolstering market growth.
In 2021, Schreiner MediPharm, a Germany-based innovative label solutions provider, introduced a tamper-proof Syringe-Closure-Wrap designed to provide clear first-opening indication for prefilled syringes. This innovation aims to enhance patient safety and maintain the integrity of prefilled syringes.
BD Dominates the Prefilled Syringes Landscape
Becton, Dickinson and Company (BD) leads the global prefilled syringes market with its extensive product portfolio, wide customer base, and strong global presence. The company recently announced a significant investment of US$1.2 billion to expand its prefilled syringes manufacturing capacity by 50%, including the establishment of a new plant in Europe and improvements to existing facilities in the US, Europe, Japan, and Mexico.
Other key players in the global prefilled syringes market include Baxter International Inc., Catalent Inc., Elcam Medical ACS. Ltd, Gerresheimer AG, Nipro Medical Corporation, Oval Medical Technologies Limited, SHL Medical AG, Stevanato Group, Terumo Corporation, Vetter Pharma-Fertigung GmbH & Co. KG, West Pharmaceutical Services, Inc., and Ypsomed Group. These companies are focusing on research and development investments to keep pace with biotech and pharma innovations, as well as on syringe modification strategies and the development of new distribution channels and value-added services.
Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2023-2030 – By Product, Technology, Grade, Application, End-user, Region: (North America, Europe, Asia Pacific, Latin America and Middle East and Africa) https://www.fairfieldmarketresearch.com/report/prefilled-syringes-market
Fairfield Market Research is a UK-based market research provider. Fairfield offers a wide spectrum of
services, ranging from customized reports to consulting solutions. With a strong European footprint, Fairfield operates globally and helps businesses navigate through business cycles, with quick responses and multi-pronged approaches. The company values an eye for insightful take on global matters, ably backed by a team of exceptionally experienced researchers. With a strong repository of syndicated market research reports that are continuously published & updated to ensure the ever-changing needs of customers are met with absolute promptness.
Fairfield Market Research
UK +44 (0)20 30025888
USA (Toll-free) +1 (844) 3829746
This press release first seen on Brilad